ライフサイエンスコーパス: crystalloid

1 6) were initially resuscitated with 10 mL/kg crystalloid.

2 ge vacuoles, they form a membrane-containing crystalloid.

3 , pigs were resuscitated with shed blood and crystalloid.

4 % CI, 1.84-4.16; both p < 0.001) compared to crystalloid.

5 health record to compare saline to balanced crystalloids.

6 eved equally fast with synthetic colloids or crystalloids.

7 branes adjacent to granular material and DNA crystalloids.

8 nal hemodynamics when compared with balanced crystalloids.

9 s not more effective than treating with only crystalloids.

10 received synthetic colloids compared to only crystalloids.

11 Intraoperatively, LIB patients received crystalloid 12 mL/kg/h and RES patients 6 mL/kg/h.

12 age, gender, comorbidities, blood products, crystalloid/12 hrs, presence of any head injury, injury

13 Patients received a median of 6.1 L of crystalloid, 13 units of RBCs, 10 units of FFP, and 1 un

14 nosis (1C); initial fluid resuscitation with crystalloid (1B) and consideration of the addition of al

15 Here we show that formation of the crystalloid-a unique and short-lived organelle of the Pl

16 se virions do not acquire nucleoids, and DNA crystalloids accumulate in the cytoplasm.

17 n study groups in the proportion of isotonic crystalloid administered that was saline.

18 ible trials comparing hydroxyethyl starch to crystalloids, albumin, or gelatin.

19 n addition to crystalloids, as compared with crystalloids alone, did not improve the rate of survival

20 er infusion of blood products is superior to crystalloids alone.

21 of 1162 patients (99.1%) receiving buffered crystalloid and 1110 of 1116 patients (99.5%) receiving

22 and retrograde cardioplegia are superior to crystalloid and antegrade cardioplegia alone for postope

23 logical effects of ONOO(-) may exist between crystalloid and blood cardioplegia (BCP) environments.

24 ndergoing DCL, implementation of DCR reduces crystalloid and blood product administration.

25 After 30 mins, crystalloid and blood with either 0.1 unit x kg(-1) x hr

26 erformed to a target hemoglobin of 8.0 g/dL; crystalloid and colloid were used for volume replacement

27 ow-dose dopamine (n = 43) versus intravenous crystalloid and matching placebos (n = 55).

28 gulated with citrate-phosphate-dextrose) and crystalloid and observed for the next 6 or 24 hours.

29 ter LVR, full resuscitation was started with crystalloid and red cells.

30 Improved resuscitation with crystalloid and shed blood minimized acute lung injury.

31 thy through permissive hypotension, limiting crystalloids and delivering higher ratios of plasma and

32 e family Brassicaceae, the PSVs lack visible crystalloids and have many small globoids dispersed thro

33 e examined the association between choice of crystalloids and in-hospital mortality during the resusc

34 -embedded proteins (BPEPs), associated with 'crystalloid' and globoid fractions.

35 ion to give is, whether it be a colloid or a crystalloid, and how and when to give it.

36 lline lattice of membranes and proteins, the crystalloid, and one or a few large phytate crystals, th

37 rising estimated blood loss, total volume of crystalloid, and other colloid/hypertonic solutions admi

38 Hyponatremia was apparent in the isotonic crystalloid- and colloid-treated animals, but not in tho

39 decades after they were first described, the crystalloids are back in the spotlight, with recent disc

40 Crystalloids are transient organelles that form in devel

41 es, anesthetic management, fluid management (crystalloids as well as hemoglobin-based oxygen-carrying

42 e sepsis, albumin replacement in addition to crystalloids, as compared with crystalloids alone, did n

43 8 hr) comprised retransfusion of shed blood, crystalloids (balanced electrolyte solution), and norepi

44 use of damage control surgery and aggressive crystalloid-based resuscitation.

45 to 90 minutes postorder; and 4) 30 mL/kg IV crystalloid bolus initiated less than or equal to 30 min

46 lloids (p<.05) and, to a lesser extent, with crystalloids, but not with albumin.

47 at baseline and received similar volumes of crystalloid by 30 days (median [interquartile range]: 1,

48 It is generally believed that crystalloid can be substituted, in whole or in part, for

49 ossover trial comparing saline with balanced crystalloids can produce well-balanced study groups and

50 arrested for 30 minutes (37 degrees C) with crystalloid cardioplegia (CCP).

51 in microbubbles within the myocardium during crystalloid cardioplegia (CP) infusion and ischemia-repe

52 earts were arrested for 60 minutes with cold crystalloid cardioplegia (iC-CCP; n=8) or with cold bloo

53 sted for 60 minutes with warm (37 degrees C) crystalloid cardioplegia (iW-CCP) (n=8) or with warm blo

54 followed by 60 minutes of intermittent cold crystalloid cardioplegia (Plegisol) and 2 hours of reper

55 he hypothesis that ONOO(-) is cardiotoxic in crystalloid cardioplegia but cardioprotective in BCP in

56 arts to 8 hours of hypothermic ischemia with crystalloid cardioplegia containing adenosine 0, 0.01, 0

57 GSH in crystalloid cardioplegia detoxifies ONOO(-) and forms ca

58 investigated whether intermittent blood and crystalloid cardioplegia differentially affect myocardia

59 Extent of myocardial protection with cold-crystalloid cardioplegia in pediatric open heart surgery

60 ONOO(-) in crystalloid cardioplegia solution induces injury to coro

61 Patients receiving crystalloid cardioplegia versus those receiving blood ca

62 sis) undergoing open heart surgery with cold-crystalloid cardioplegia were included in the study.

63 y donor hearts preserved by single dose cold crystalloid cardioplegia with greater than 8 hours of co

64 500 micromol/L GSH, whereas 1 group received crystalloid cardioplegia without GSH (CCP, n=6).

65 wed by 60 minutes of CPB, with 45 minutes of crystalloid cardioplegia, then 90 minutes of post-CPB re

66 to enhance myocardial protection afforded by crystalloid cardioplegia, volatile anesthesia and hypoth

67 jury in pediatric patients protected by cold-crystalloid cardioplegia.

68 ompared with respect to the use of blood and crystalloid cardioplegia.

69 nction and systolic function when present in crystalloid cardioplegia.

70 dioplegic arrest and rewarming, incubated in crystalloid cardioplegic solution (24 mEq/L K+, 4 degree

71 the partial dilution of blood in 4:1 (blood:crystalloid) cardioplegic solutions may nullify these ad

72 balance, accounting for patient morphometry, crystalloid, colloid, blood products, urine, blood loss,

73 The 'crystalloid-colloid debate' continues, and has led to an

74 rhage should occur in successive steps using crystalloids, colloids, and red blood cells (RBCs) in th

75 Crystalloids, colloids, blood, inotropes, and vasopresso

76 tional coagulopathy after resuscitation with crystalloids/colloids clinically often appears as diffus

77 fluid therapy in the ICU, use of a buffered crystalloid compared with saline did not reduce the risk

78 rious ice nucleating proteins, microbes, and crystalloid compounds.

79 Crystalloid CP perfusion and I-R resulted in extensive l

80 bubble transit was markedly prolonged during crystalloid CP perfusion.

81 effect was partially reversed in the case of crystalloid CP when it was followed by blood CP.

82 nts with hypovolemia, the use of colloids vs crystalloids did not result in a significant difference

83 Consistent with other proteins that induce crystalloid ER, viperin self-associates, and it does so

84 phipathic alpha-helix fused to dsRed induced crystalloid ER.

85 Among patients receiving crystalloid fluid therapy in the ICU, use of a buffered

86 All patients admitted to the ICU requiring crystalloid fluid therapy were eligible for inclusion.

87 All measures of crystalloid fluid volume were reduced while patients wer

88 esuscitation with blood or a large volume of crystalloid fluid.

89 CPR is a rapid infusion of large-volume cold crystalloid fluid.

90 vity as the result of dilution followed with crystalloid fluids and artificial colloids (dextran and

91 nce between designs (hyperoncotic albumin vs crystalloid fluids) among these 18 comparisons.

92 Database, the use of a calcium-free balanced crystalloid for replacement of fluid losses on the day o

93 Therapy in the Colloids Versus Crystalloids for the Resuscitation of the Critically Ill

94 ked study fluid, either saline or a buffered crystalloid, for alternating 7-week treatment blocks.

95 s of developing ookinetes and is involved in crystalloid formation.

96 Forced diuresis with intravenous crystalloid, furosemide, and mannitol if hemodynamics pe

97 ndomized to forced diuresis with intravenous crystalloid, furosemide, mannitol (if pulmonary capillar

98 Cumulative crystalloid given (median, range, mL) days 0 to 3 was LI

99 made up a larger proportion of the isotonic crystalloid given in the saline group than in the balanc

100 thetized pig can be reversed or prevented by crystalloids given in a volume equivalent to Advanced Tr

101 ed eosinophils, which were probably immature crystalloid granules in eosinophil myelocytes.

102 ven in the saline group than in the balanced crystalloid group (91% vs. 21%; P < 0.001).

103 luid was needed over the first 4 days in the crystalloid group (fluid ratios 1.4:1 [crystalloids to h

104 , 87 of 1152 patients (7.6%) in the buffered crystalloid group and 95 of 1110 patients (8.6%) in the

105 albumin group and 288 of 900 (32.0%) in the crystalloid group had died (relative risk in the albumin

106 albumin group and 389 of 893 (43.6%) in the crystalloid group had died (relative risk, 0.94; 95% CI,

107 Fluid intake was higher in the crystalloid group only during the first 20 hours.

108 In the buffered crystalloid group, 102 of 1067 patients (9.6%) developed

109 albumin group, as compared with those in the crystalloid group, had a higher mean arterial pressure (

110 In the buffered crystalloid group, RRT was used in 38 of 1152 patients (

111 ay 5, fluid balance was more negative in the crystalloid group.

112 red with a net positive fluid balance in the crystalloid group.

113 ) in colloids group vs 390 deaths (27.0%) in crystalloids group (relative risk [RR], 0.96 [95% CI, 0.

114 ) in colloids group vs 493 deaths (34.2%) in crystalloids group (RR, 0.92 [95% CI, 0.86 to 0.99]; P =

115 (11.0%) in colloids group vs 181 (12.5%) in crystalloids group (RR, 0.93 [95% CI, 0.83 to 1.03]; P =

116 cal ventilation in the colloids group vs the crystalloids group by 7 days (mean: 2.1 vs 1.8 days, res

117 wed higher mortality with starches than with crystalloids (high confidence) and lower mortality with

118 ocol groups: euvolemic (3 mLkg/hour isotonic crystalloid), hypervolemic (15 mL/kg/hour isotonic cryst

119 Isotonic saline is the most commonly used crystalloid in the ICU, but recent evidence suggests tha

120 gelatin in 2006-2008, n = 2,324; and 3) only crystalloids in 2008-2010, n = 2,017.

121 d, 4% gelatin in the second period, and only crystalloids in the third period.

122 orrhagic shock may receive several liters of crystalloid, in addition to colloid solutions, in an att

123 um with accumulation of large phagosomes and crystalloid inclusions.

124 A crystalloid infusion of 0.9% saline did not alter any of

125 Crystalloid infusion revealed best results in mortality

126 6 and resulted in a decrease in mean 24-hour crystalloid infusion volume (6.1-3.2 L) and increased fr

127 The mean 24-hour crystalloid infusion volume and number of the total bloo

128 venous pressure was kept constant by colloid/crystalloid infusion.

129 three hundred thirty-six patients (48%) had crystalloid initiated in 30 minutes or lesser versus 2,3

130 Earlier crystalloid initiation was associated with decreased mor

131 Crystalloid initiation was faster for emergency departme

132 The primary exposure was crystalloid initiation within 30 minutes or lesser, 31-1

133 ntensive care unit volume, and initial 24-hr crystalloid intensive care unit volume were all lower in

134 ume during the first 48 hrs post burn, total crystalloid intensive care unit volume, and initial 24-h

135 n saline (0.9% sodium chloride) and balanced crystalloids (lactated Ringer's solution or Plasma-Lyte

136 nated PSVs from Brassica napus and defined a crystalloid-like fraction that contained integral membra

137 DCR patients received less crystalloids (median: 14 L vs 5 L), red blood cells (13

138 ) and lower mortality with albumin than with crystalloids (moderate confidence) or starches (moderate

139 ovolemia to achieve a minimum of 30 mL/kg of crystalloids (more rapid administration and greater amou

140 yethyl starch n = 360, gelatin n = 352, only crystalloids n = 334).

141 yethyl starches, or 4% or 20% of albumin) or crystalloids (n = 1443; isotonic or hypertonic saline or

142 ts assigned to saline (n = 454) and balanced crystalloids (n = 520) were similar at baseline and rece

143 Animals were treated with different crystalloids (NaCl 0.9% (NaCl), Ringer's acetate (RA)) o

144 ed in macrogametocytes, gets targeted to the crystalloids of developing ookinetes and is involved in

145 d integral membrane protein markers found in crystalloids of other plants.

146 chosen method (1C); administration of either crystalloid or colloid fluid resuscitation (1B); fluid c

147 uence of volume resuscitation with different crystalloid or colloid solutions on liver and intestine

148 Low-volume crystalloid or hemoglobin glutamer-200 resuscitation pos

149 nts with sepsis, resuscitation with balanced crystalloids or albumin compared with other fluids seems

150 hock associated with hypovolemia, the use of crystalloids or albumin to deliver a bolus of 20 mL/kg o

151 However, whether balanced or unbalanced crystalloids or natural or synthetic colloids confer a s

152 or albumin to deliver a bolus of 20 mL/kg of crystalloids (or albumin equivalent) over 5 to 10 mins (

153 lloid), hypervolemic (15 mL/kg/hour isotonic crystalloid), or hypertonic (3 mL/kg/hour isotonic cryst

154 dentify a parasite protein involved with the crystalloid organelle, and suggest a novel protein-traff

155 induced formation of karmellae, whorls, and crystalloid OSER structures.

156 sion of 1, 2, 3, or 4 mL/Kg (body weight) of crystalloid over 5 minutes.

157 some monocotyledonous plants, but additional crystalloid P-proteins, known as forisomes, have evolved

158 patients received more fluid (4.0 vs. 2.5 L crystalloid, p < .001), earlier antibiotics (90 vs. 120

159 Isolated rat hearts were crystalloid perfused with the Langendorff method and sub

160 These results contrast with isolated crystalloid-perfused heart experiments and suggest that

161 In additional experiments, using blood- and crystalloid-perfused hearts, we describe the relationshi

162 The isolated crystalloid-perfused working rat heart preparation was u

163 e have developed a simplified system of cold crystalloid perfusion and compared it with standard cold

164 Continuous cold crystalloid perfusion in a canine model of DCD: (1) faci

165 l starch and gelatin periods compared to the crystalloid period (odds ratio, 1.46 [1.08, 1.97]; p = 0

166 in the gelatin period, and 224 mL/kg in the crystalloid period.

167 mponents of forisomes, which are specialized crystalloid phloem proteins found solely in the Fabaceae

168 ts were randomized to receive either PGE1 or crystalloid placebo intravenously after allograft revasc

169 tes of intermittent 4 degrees C hyperkalemic crystalloid (Plegisol) or BCP with (+) or without (-) 5

170 lloid), or hypertonic (3 mL/kg/hour isotonic crystalloid plus 1.2 mL/kg/hour 7.5% NaCl).

171 hour, then resuscitation with shed blood and crystalloid, plus contamination).

172 Patients received a 5% albumin prime or a crystalloid prime.

173 4 patients had an albumin prime and 42 had a crystalloid prime.

174 Whether use of balanced crystalloids rather than saline affects patient outcomes

175 well-balanced study groups and separation in crystalloid receipt.

176 of the crystalloid, the correct targeting of crystalloid-resident protein LAP2, and malaria parasite

177 of the 40-year-old standard of large volume crystalloid resuscitation for traumatic shock, greatly r

178 ults with severe falciparum malaria received crystalloid resuscitation guided by transpulmonary therm

179 Recognition of the limitations of standard crystalloid resuscitation has led to exploration for alt

180 e significant public health implications, as crystalloid resuscitation is nearly universal in sepsis.

181 The majority recovered well with standard crystalloid resuscitation or following a single colloid

182 is study were to 1) assess patterns of early crystalloid resuscitation provided to sepsis and septic

183 control and preload driven excessive use of crystalloid resuscitation were identified as modifiable

184 mine the association between time to initial crystalloid resuscitation with hospital mortality, mecha

185 blood was returned, i.e., immediately before crystalloid resuscitation, and were killed at 2 hrs afte

186 ve shown that resuscitation with colloid and crystalloid show no difference in outcomes in critically

187 e administration of only a minimal volume of crystalloid solution (2.8 mL/kg) and the absence of bloo

188 0.9% saline (30,994 patients) or a balanced crystalloid solution (926 patients) on the day of surger

189 on, fluid resuscitation was initiated with a crystalloid solution (Lactated Ringers).

190 In addition, the volume of crystalloid solution administered during the first 24 hr

191 ther 20% albumin and crystalloid solution or crystalloid solution alone.

192 Pharmacologic modulation, crystalloid solution at 4 degrees C, and induction of he

193 ed method for infusion of O2, dissolved in a crystalloid solution at extremely high concentrations, i

194 depend on its environment and (2) ONOO(-) in crystalloid solution impairs postcardioplegia systolic a

195 ts (ICUs), to receive either 20% albumin and crystalloid solution or crystalloid solution alone.

196 LP induced septic rats, whereas the balanced crystalloid solution showed stabilization of macro- and

197 is a physiologic, balanced multielectrolyte crystalloid solution that approximates the electrolyte c

198 ersus Plasma-Lyte A, a calcium-free balanced crystalloid solution, hypothesizing that Plasma-Lyte A w

199 o determine whether the volumes of blood and crystalloid solutions administered in the early posttrau

200 tion to albumin and crystalloid solutions or crystalloid solutions alone.

201 d debate continues about the role of various crystalloid solutions and albumin.

202 ume-dependent and linear fashion, the non-RL crystalloid solutions decreased the lactate concentratio

203 porting the choice of intravenous colloid vs crystalloid solutions for management of hypovolemic shoc

204 c) Even small amounts of non-RL crystalloid solutions in catheters used for blood sampli

205 on of therapeutic components, beginning with crystalloid solutions infused to replace lost intravascu

206 ens are drawn from indwelling catheters, all crystalloid solutions must be cleared from the line.

207 Randomization to albumin and crystalloid solutions or crystalloid solutions alone.

208 0.01, 0.05, 0.10, 0.50, or 1.0 mL of various crystalloid solutions, containing or not containing RL,

209 deleterious effects of nitric oxide (NO) in crystalloid solutions, possibly due to a lack of detoxif

210 st the hypothesis that even small amounts of crystalloid solutions, which are inadequately "cleared"

211 were adequately cleared (removal > 5 mL) of crystalloid solutions.

212 The CNTL involved intravenous crystalloid solutions.

213 otein was targeted to peroxisomes and formed crystalloid structures or cores similar to those present

214 ht starch (low confidence) and with balanced crystalloids than with saline (low confidence) and low-

215 rotein is essential for the formation of the crystalloid, the correct targeting of crystalloid-reside

216 s article we review recent studies involving crystalloids, the 'new colloids', and on the amount and

217 o continue to require substantial amounts of crystalloid to maintain adequate mean arterial pressure

218 resuscitated with shed autologous blood and crystalloid to reach baseline cardiac output (0.9%), and

219 stalloids to hydroxyethyl starch] and 1.1:1 [crystalloids to gelatin]).

220 n the crystalloid group (fluid ratios 1.4:1 [crystalloids to hydroxyethyl starch] and 1.1:1 [crystall

221 Among these are the crystalloids: transient structures whose presence is res

222 After 1 hr, shed blood plus supplemental crystalloid (twice the shed blood volume) plus either ac

223 The intravenous crystalloid used in the unit alternated monthly between

224 s 4% blood cardioplegia) and late death (24% crystalloid versus 21% blood cardioplegia) statistics we

225 Despite this, early death (6% crystalloid versus 4% blood cardioplegia) and late death

226 There has been a shift toward a reduced crystalloid volume and the recreation of whole blood fro

227 Total crystalloid volume during the first 48 hrs post burn, to

228 e monitoring, colloids, steroids, and larger crystalloid volumes (median 7 vs 5 L).

229 ally similar except that men required higher crystalloid volumes, more often had a history of alcohol

230 After 1 hr shock, shed blood plus crystalloid was administered for resuscitation.

231 Crystalloid was initiated significantly later with comor

232 cold (4 degrees C) antegrade BCP (8:1 blood:crystalloid) was delivered every 20 minutes for the firs

233 After 1 hr, shed blood and supplemental crystalloid were administered for resuscitation.

234 nstead, aberrant spherical virions and large crystalloids were seen.

235 (hazard ratio, 0.53-0.75; p < 0.001), 1-2 L crystalloids within the first 6 hours (hazard ratio 0.67